title: Antibody responses elicited in mice immunized with Bacillus subtilis vaccine strains expressing Stx2B subunit of enterohaemorragic Escherichia coli O157:H7.
abstract: No effective vaccine or immunotherapy is presently available for patients with the hemolytic uremic syndrome (HUS) induced by Shiga-like toxin (Stx) produced by enterohaemorragic Escherichia coli (EHEC) strains, such as those belonging to the O157:H7 serotype. In this work we evaluated the performance of Bacillus subtilis strains, a harmless spore former gram-positive bacterium species, as a vaccine vehicle for the expression of Stx2B subunit (Stx2B). A recombinant B. subtilis vaccine strain expressing Stx2B under the control of a stress inducible promoter was delivered to BALB/c mice via oral, nasal or subcutaneous routes using both vegetative cells and spores. Mice immunized with vegetative cells by the oral route developed low but specific anti-Stx2B serum IgG and fecal IgA responses while mice immunized with recombinant spores developed anti-Stx2B responses only after administration via the parenteral route. Nonetheless, serum anti-Stx2B antibodies raised in mice immunized with the recombinant B. subtilis strain did not inhibit the toxic effects of the native toxin, both under in vitro and in vivo conditions, suggesting that either the quantity or the quality of the induced immune response did not support an effective neutralization of Stx2 produced by EHEC strains.
authors.affiliation: Universidade de São Paulo, Departamento de Microbiologia , São Paulo, SP , Brasil.
authors.forename: P A D P
authors.initials: PA
authors.lastname: Gomes
authors.forename: L V
authors.initials: LV
authors.lastname: Bentancor
authors.forename: J D
authors.initials: JD
authors.lastname: Paccez
authors.forename: M E
authors.initials: ME
authors.lastname: Sbrogio-Almeida
authors.forename: M S
authors.initials: MS
authors.lastname: Palermo
authors.forename: R C C
authors.initials: RC
authors.lastname: Ferreira
authors.forename: L C S
authors.initials: LC
authors.lastname: Ferreira
keywords: Bacillus subtilis; EHEC; HUS; Stx; vaccines
references.citation: Vaccine. 2006 Apr 5;24(15):2935-43
references.pmid: 16503367
references.citation: Infect Immun. 2003 May;71(5):2810-8
references.pmid: 12704155
references.citation: Infect Immun. 1997 Jul;65(7):2509-16
references.pmid: 9199412
references.citation: Vaccine. 2007 Jan 4;25(2):346-55
references.pmid: 17007969
references.citation: An Acad Bras Cienc. 2005 Mar;77(1):113-24
references.pmid: 15692682
references.citation: J Infect Dis. 2004 Feb 1;189(3):355-9
references.pmid: 14745691
references.citation: Vaccine. 2001 Feb 28;19(15-16):2061-70
references.pmid: 11228378
references.citation: Vaccine. 2007 Jun 11;25(24):4671-80
references.pmid: 17498854
references.citation: Infect Immun. 2005 Oct;73(10):6523-9
references.pmid: 16177326
references.citation: Infect Immun. 2003 Jul;71(7):3971-8
references.pmid: 12819084
references.citation: Clin Microbiol Rev. 1998 Jul;11(3):450-79
references.pmid: 9665978
references.citation: Vaccine. 2008 Jul 29;26(32):3998-4005
references.pmid: 18597902
references.citation: Vaccine. 2007 Jan 4;25(2):356-65
references.pmid: 16920233
references.citation: Vaccine. 2006 May 8;24(19):4122-9
references.pmid: 16551486
references.citation: Plasmid. 2005 Nov;54(3):241-8
references.pmid: 16005967
references.citation: J Infect Dis. 2001 Feb 1;183(3):435-43
references.pmid: 11133375
references.citation: Clin Microbiol Rev. 1998 Jan;11(1):142-201
references.pmid: 9457432
references.citation: Vaccine. 2003 Oct 1;21(27-30):4215-24
references.pmid: 14505901
references.citation: Clin Vaccine Immunol. 2008 Feb;15(2):359-66
references.pmid: 18003816